Acta Scientific PAEDIATRICS (ISSN: 2581-883X)

Research Article Volume 5 Issue 11

Invasive Disease in Pediatric Population - 10 Year Review

Adriana Costa*, Sara Completo and Paula Correia

Department of Child and Youth, Hospital Professor, Doutor Frenando Fonseca, EPE, Portugal

*Corresponding Author: Adriana Costa, Department of Child and Youth, Hospital Professor, Doutor Frenando Fonseca, EPE, Portugal.

Received: August 24, 2022; Published: November 16, 2022


Introduction: Pediatric invasive disease (PID) is confirmed by isolation of a microorganism from a normally sterile site. The incidence of infection due to multi-drug resistant (MDR) bacteria is increasing worldwide, which threatens the effective treatment of infections. This study aims to characterize PID during 10-years in a Portuguese hospital: morbimortality, risk factors and antimicrobial susceptibility.

Methods: Descriptive retrospective study of PID in children aged between 28 days and 18 years old, attended in a pediatric department from 2010 to 2020.

Results: 236 PID episodes were identified among 230 patients. Comorbidities were present in 25.4%, predominantly prematurity (37.7%) and sickle cell disease (30.4%). The median age was 21.4-month-old. The most common diagnosis was bacteremia without a source (34%) and pneumonia (18%). Sepsis occurred in 17.4%. Clinical sequelae were present in 17.4%. Pneumonia and meningitis were associated to worse outcomes (p-value < 0.001). Mortality rate was 1.3%. Were isolated 279 microorganisms: 88% in blood; 6% in cerebrospinal fluid; 4% in pleural liquid; 2% in joint fluid. The most frequently isolated were Streptococcus pneumoniae (22.6%) and methicillin-susceptible Staphylococcus aureus (13.3%); 7.5% were MDR bacteria, of which 33% were community-associated.

Conclusion: PID is still an important cause of morbimortality. The incidence of MDR microorganisms is alarming, which alerts to the problem of wide use of antibiotics, especially broad spectrum.

Keywords: Bacteria; Fungi; Infectious Disease; Multi-Drug Resistance; Antimicrobial Susceptibility


  1. Balsells E., et al. “Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis”. PLOS One5 (2017): e0177113.
  2. Tan TQ. “Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines”. Clinical Microbiology Reviews 3 (2012): 409-419.
  3. Armstrong AE., et al. “Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease”. Pediatric Blood Cancer7 (2019): e27734.
  4. Ó Maoldomhnaigh C., et al. “Invasive meningococcal disease in children in Ireland, 2001-2011”. Archives of Disease in Childhood 12 (2016): 1125-1129.
  5. Fisher BT., et al. “Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review”. Journal of the Pediatric Infectious Diseases Society 3 (2018): 191-198.
  6. Briere EC., et al. “Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, Centers for Disease Control and Prevention”. Recommendations and Reports1 (2014).
  7. Paintsil E. “Pediatric community-acquired methicillin-resistant Staphylococcus aureus infection and colonization: trends and management”. Current Opinion in Pediatrics 1 (2017): 75-82.
  8. Van Duin D and Paterson DL. “Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned”. Infectious Disease Clinics of North America 2 (2016): 377-390.
  9. Thaulow CM., et al. “Epidemiology and Antimicrobial Susceptibility of Invasive Bacterial Infections in Children-A Population-Based Study from Norway”. The Pediatric Infectious Disease Journal 5 (2021): 403-410.
  10. Hennaut E., et al. “Prospective Cohort Study Investigating the Safety and Efficacy of Ambulatory Treatment with Oral Cefuroxime-Axetil in Febrile Children with Urinary Tract Infection”. Frontiers in Pediatrics 6 (2018): 237.
  11. Pana ZD., et al. “Epidemiology of Invasive Fungal Disease in Children”. Journal of the Pediatric Infectious Diseases Society 1 (2017): S3-S1.
  12. Edmond K., et al. “Long term sequelae from childhood pneumonia; systematic review and meta-analysis”. PLOS one2 (2012): e31239.
  13. Stein-Zamir C., et al. “The clinical features and long-term sequelae of invasive meningococcal disease in children”. The Pediatric Infectious Disease Journal 7 (2014): 777-779.
  14. In bengali)” (2021).


Citation: Adriana Costa., et al. “Invasive Disease in Pediatric Population - 10 Year Review". Acta Scientific Paediatrics 5.12 (2022): 10-18.


Copyright: © 2022 Adriana Costa., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US